NORMAL SITUATION

EVALUMED

Export PDF

Financial year 2022 · closed on 31/12/2022

Net result

-864,9 €

-1291.3% YoY

Gross margin

71,1 k €

-21.4% YoY

Equity

37,6 k €

-2.2% YoY

Company — Normal situation.

What does EVALUMED do?

EVALUMED is a company registered in Belgium.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0444.056.694

Legal form

Private company with limited liability

Contributed capital

25 000,00 €

Latest accounts

31/12/2022

Joint committees (2)

30502
330

Signals

Solid equityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	71,1 k €	-21.4%	90,5 k €	+0.7%	89,9 k €	-4.4%	94,0 k €	-6.7%	100,8 k €	-7.9%	109,5 k €	-7.7%	118,6 k €	+39.6%	85,0 k €	-22.6%	109,7 k €	+6.0%	103,5 k €	+7.2%	96,5 k €	+0.2%	96,3 k €	-11.3%	108,6 k €	+24.2%	87,4 k €	-13.3%	100,7 k €	+5.5%	95,5 k €	+5.4%	90,6 k €
EBITDA	-62,7 €	-104%	1,5 k €	+148%	-3,1 k €	-130%	10,2 k €	-7.5%	11,0 k €	-48.1%	21,2 k €	-41.0%	36,0 k €	+822%	3,9 k €	-86.3%	28,5 k €	+37.4%	20,7 k €	+6.2%	19,5 k €	+0.8%	19,4 k €	-45.0%	35,2 k €	+136%	14,9 k €	-47.9%	28,5 k €	+3.1%	27,7 k €	+24.5%	22,2 k €
Operating result	-62,7 €	-104%	1,5 k €	+112%	-12,5 k €	-339%	-2,8 k €	-210%	2,6 k €	-74.1%	10,0 k €	-59.6%	24,7 k €	+427%	-7,6 k €	-143%	17,8 k €	+61.1%	11,0 k €	+9.5%	10,1 k €	+7.6%	9,4 k €	-62.8%	25,2 k €	+414%	4,9 k €	-68.1%	15,3 k €	-13.0%	17,6 k €	+186%	6,2 k €
Net result	-864,9 €	-1291%	72,6 €	+100%	-14,6 k €	-36.4%	-10,7 k €	-566%	2,3 k €	-57.3%	5,4 k €	-62.0%	14,2 k €	+177%	-18,4 k €	-236%	13,6 k €	+138%	5,7 k €	+1034%	502,8 €	-88.5%	4,4 k €	-56.6%	10,0 k €	+279%	-5,6 k €	-239%	4,0 k €	-49.3%	7,9 k €	+280%	-4,4 k €
Balance sheet
Equity	37,6 k €	-2.2%	38,5 k €	+0.2%	38,4 k €	-27.5%	53,0 k €	-16.8%	63,7 k €	+3.7%	61,4 k €	+9.6%	56,1 k €	+33.8%	41,9 k €	-30.5%	60,3 k €	+29.0%	46,7 k €	+13.9%	41,0 k €	+1.2%	40,5 k €	+12.0%	36,2 k €	+38.3%	26,2 k €	-17.7%	31,8 k €	+14.5%	27,8 k €	+40.1%	19,8 k €
Total assets	61,0 k €	-37.2%	97,0 k €	+12.8%	86,0 k €	-22.4%	110,8 k €	-21.0%	140,2 k €	-18.4%	171,7 k €	+2.5%	167,4 k €	+8.0%	155,0 k €	-7.3%	167,3 k €	-5.2%	176,5 k €	+2.1%	172,9 k €	-4.8%	181,6 k €	-1.2%	183,8 k €	-2.3%	188,2 k €	-4.5%	197,0 k €	-9.2%	216,8 k €	-7.1%	233,4 k €
Cash	–		14,5 k €	+235%	4,3 k €	+194%	1,5 k €		–		543,8 €	-94.6%	10,1 k €	+1205%	770,9 €	-5.4%	814,7 €	+14.3%	713,0 €	+217%	225,0 €	-88.9%	2,0 k €	+93.3%	1,0 k €	+3156%	32,2 €		–		7,2 k €	-37.6%	11,6 k €
Debts	23,3 k €	-60.1%	58,5 k €	+23.0%	47,6 k €	-17.6%	57,8 k €	-24.4%	76,4 k €	-30.7%	110,2 k €	-1.0%	111,4 k €	-1.5%	113,1 k €	+5.7%	106,9 k €	-17.6%	129,7 k €	-1.6%	131,9 k €	-6.5%	141,0 k €	-4.5%	147,6 k €	-8.9%	162,0 k €	-1.9%	165,1 k €	-12.7%	189,1 k €	-11.5%	213,6 k €
Other
Workforce	–		–		–		–		–		–		–		1,8 ETP	0.0%	1,8 ETP	0.0%	1,8 ETP	0.0%	1,8 ETP	0.0%	1,8 ETP	0.0%	1,8 ETP	+5.9%	1,7 ETP	0.0%	1,7 ETP	0.0%	1,7 ETP	-5.6%	1,8 ETP

Governance

Board of directors

Seen on filing of 31/12/2022 · 2 active · 6 ended

Active mandates

Gert Geuens

Director · since 05 juin 2014

Active

Vera Guastavino

Director · since 05 juin 2014

Active

Ended mandates

Gert Geuens

Manager · since 05 juin 2014

Ended

Vera Guastavino

Manager · since 05 juin 2014

Ended

Gert Geuens

Manager · since 19 décembre 2003 · until 05 juin 2014

Ended

Gert GEUENS

Manager · since 19 décembre 2003

Ended

Annual accounts

Full financial information

	2022	2021	2020	2019	2018	2017
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2022	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017
Closing of the financial year	31/12/2022	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/04/2023	28/06/2022	30/06/2021	16/06/2020	25/06/2019	08/06/2018
General meeting	31/03/2023	02/06/2022	03/06/2021	04/06/2020	06/06/2019	07/06/2018
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

32 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2022	31/03/2023	07/04/2023	Dutch	PDF
Micro model	31/12/2021	02/06/2022	28/06/2022	Dutch	PDF
Micro model	31/12/2020	03/06/2021	30/06/2021	Dutch	PDF
Micro model	31/12/2019	04/06/2020	16/06/2020	Dutch	PDF
Micro model	31/12/2018	06/06/2019	25/06/2019	Dutch	PDF
Micro model	31/12/2017	07/06/2018	08/06/2018	Dutch	PDF
Micro model	31/12/2016	01/06/2017	12/06/2017	Dutch	PDF
Abridged model	31/12/2015	02/06/2016	13/06/2016	Dutch	PDF
Abridged model	31/12/2014	04/06/2015	09/06/2015	Dutch	PDF
Abridged model	31/12/2013	05/06/2014	12/06/2014	Dutch	PDF
Abridged model	31/12/2012	06/06/2013	13/06/2013	Dutch	PDF
Abridged model	31/12/2011	07/06/2012	21/06/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	30/06/2011	Dutch	PDF
Abridged model	31/12/2009	03/06/2010	17/06/2010	Dutch	PDF
Abridged model	31/12/2008	04/06/2009	23/06/2009	Dutch	PDF
Abridged model	31/12/2007	05/06/2008	13/06/2008	Dutch	PDF
Abridged model	31/12/2006	07/06/2007	05/07/2007	Dutch	PDF
Abridged model	31/12/2005	29/06/2006	11/07/2006	Dutch	PDF
Abridged model	31/12/2004	02/06/2005	17/06/2005	Dutch	PDF
Abridged model	31/12/2003	03/06/2004	25/06/2004	Dutch	PDF
Abridged model	31/12/2002	05/06/2003	18/06/2003	Dutch	PDF
Abridged model	31/12/2001	06/06/2002	19/06/2002	Dutch	PDF
Abridged model	31/12/2000	07/06/2001	08/06/2001	Dutch	PDF
Abridged model	31/12/1999	02/06/2000	13/06/2000	Dutch	PDF

View all 32 filings

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2022 · 2 active · 6 ended

Active mandates

Gert Geuens

Director · since 05 juin 2014

Active

Vera Guastavino

Director · since 05 juin 2014

Active

Ended mandates

Gert Geuens

Manager · since 05 juin 2014

Ended

Vera Guastavino

Manager · since 05 juin 2014

Ended

Gert Geuens

Manager · since 19 décembre 2003 · until 05 juin 2014

Ended

Gert GEUENS

Manager · since 19 décembre 2003

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2022
Annual accounts 2022-864,9 €↓
2021
Annual accounts 202172,6 €↑
2020
Annual accounts 2020-14,6 k €↓
2019
Annual accounts 2019-10,7 k €↓
2018
Annual accounts 20182,3 k €↓
2017
Annual accounts 20175,4 k €↓
2016
Annual accounts 201614,2 k €↑
2015
Annual accounts 2015-18,4 k €↓
2014
Annual accounts 201413,6 k €↑
2013
Annual accounts 20135,7 k €↑
2012
Annual accounts 2012502,8 €↓
2011
Annual accounts 20114,4 k €↓
2010
Annual accounts 201010,0 k €↑
2009
Annual accounts 2009-5,6 k €↓
2008
Annual accounts 20084,0 k €↓
2007
Annual accounts 20077,9 k €↑
2006
Annual accounts 2006-4,4 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

EVALUMED

Overview

What does EVALUMED do?

Trend over 17 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline